Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$0.99
+3.64%
Mkt Cap $610.41M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+494.9%
Consensus $5.89 vs current $0.99
NASDAQ·Healthcare·Biotechnology
$0.99
+3.64%
Mkt Cap $610.41M
Buy
2
Hold
0
Sell
0
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+494.9%
Consensus $5.89 vs current $0.99